These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10449995)

  • 21. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma.
    Ye K; Xu JH; Sun YF; Lin JA; Zheng ZG
    Genet Mol Res; 2014 Aug; 13(3):6411-9. PubMed ID: 25158259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
    Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
    Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
    Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
    Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
    Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus.
    Liu JF; Jamieson G; Wu TC; Zhang SW; Wang QZ; Drew P
    Dis Esophagus; 2006; 19(5):350-4. PubMed ID: 16984531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Amano J
    Dis Esophagus; 2002; 15(1):67-73. PubMed ID: 12060046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
    Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
    J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
    J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
    Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of thymidine phosphorylase in human gastric carcinoma.
    Takebayashi Y; Miyadera K; Akiyama S; Hokita S; Yamada K; Akiba S; Yamada Y; Sumizawa T; Aikou T
    Jpn J Cancer Res; 1996 Mar; 87(3):288-95. PubMed ID: 8613432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma.
    Niwa Y; Koike M; Hattori M; Iwata N; Takami H; Hayashi M; Tanaka C; Kobayashi D; Kanda M; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23(2):611-8. PubMed ID: 26289807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
    Zhang HL; Chen LQ; Liu RL; Shi YT; He M; Meng XL; Bai SX; Ping YM
    Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate.
    Tabira Y; Kitamura N; Yoshioka M; Tanaka M; Nakano K; Toyota N; Mori T
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):737-40. PubMed ID: 10597014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagectomy.
    Yamasaki M; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2014 Sep; 21(9):2850-6. PubMed ID: 24728822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity and clinical role of thymidine phosphorylase activity in gastric cancer.
    Kakeji Y; Maehara Y; Shibahara K; Hasuda S; Oshiro T; Baba H; Kohnoe S; Sugimachi K
    Oncol Rep; 1999; 6(6):1213-6. PubMed ID: 10523683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.